BCGM Wealth Management LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

BCGM Wealth Management LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,858 shares of the healthcare conglomerate’s stock after purchasing an additional 143 shares during the quarter. BCGM Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,952,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. DecisionPoint Financial LLC increased its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group in the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at $57,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 7.3 %

UnitedHealth Group stock opened at $465.58 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average is $519.27 and its 200 day moving average is $560.44. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.